Rocket Lab's stock dropped 6.6% to $54.97 in after-hours trading Monday, after a quarterly net loss of $79.7 million wiped out the glow of a revenue beat. The company reported third-quarter revenue of $267.8 million, up 73% year over year and above the $255.71 million analysts had expected, according to Benzinga. But the loss of 12 cents per share came in far wider than the 6-cent loss Wall Street forecast.

The numbers tell a story of growth bought with cash. Net loss widened from $18.3 million a year earlier, while operating loss climbed to $79.2 million from $59.0 million. Two one-off items drove much of the damage: a $27.3 million loss on extinguishment of debt and $21.3 million in transaction costs.

Tax timing made the comparison worse. Rocket Lab booked a $3.5 million income tax provision this quarter, against a $41.1 million benefit in the same period last year. Strip out the noise, and the underlying picture improves: adjusted EBITDA loss narrowed to $18.0 million from $26.3 million, and operating cash flow turned positive at $7.2 million on a GAAP basis.

What does the backlog signal?

For practitioners, the more consequential figure sits below the income statement. Backlog hit a record $3.57 billion, up 52% from the end of the second quarter. The company signed roughly $1 billion in new launch contracts across its Electron, HASTE and Neutron rockets, plus another $470 million for space systems.

That pipeline now covers 117 launches in total. It is the clearest evidence that demand for Rocket Lab's vehicles is scaling faster than its losses.

Is Neutron the real story?

The medium-lift Neutron rocket did the heavy lifting in the quarter. Constellation operators signed more than $515 million in Neutron contracts, lifting that vehicle's backlog to 16 missions. Rocket Lab said the base launch price rose to $70 million for several of those missions — a pricing level that puts Neutron in direct competition with SpaceX's Falcon 9 class of vehicles rather than the small-lift market where Electron lives.

The timeline, however, keeps slipping. The maiden flight is now slated for 2027 at the earliest. Rocket Lab had formalized the delay in an October filing with the Securities and Exchange Commission, saying the shift came as the team continued development and added process improvements. The company had originally planned for the reusable rocket to debut in late 2025.

Until Neutron flies, Electron and HASTE remain what the company describes as its current launch vehicles.

What should investors watch in the fourth quarter?

Management guided to fourth-quarter revenue of $270 million to $290 million, implying continued sequential growth. It expects an adjusted EBITDA loss of $14 million to $20 million — a further narrowing if delivered — and GAAP gross margins of 34% to 36%.

The immediate read: the market punished the headline loss, but the underlying metrics — narrowing EBITDA loss, positive operating cash flow and a backlog growing at 52% in a single quarter — point to a company scaling into its spending rather than away from it. The 2027 Neutron date remains the variable that will decide whether that backlog converts into revenue on schedule.